SOS1 and KRAS, but not SOS2, have been implicated in human rasopathies, including mutations in SOS1 and KRAS in Noonan syndrome and KRAS mutations in cardiofaciocutaneous syndrome (31). Here, KRAS is linked to cardiofaciocutaneous syndrome.